Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a National Institutes of Health study released last week in JAMA Network Open. The researchers also found a downward trend of buprenorphine misuse between 2015 and 2019 among those with an opioid use disorder. Individuals who received no drug use treatment and those in rural areas were more likely to misuse the medication.

“This study provides further evidence to support the need for expanded access to proven treatment approaches, such as buprenorphine therapy, despite the remaining stigma and prejudice that remains for people with addiction and the medications used to treat it,” said National Institute on Drug Abuse Director Nora Volkow, M.D. 
 

Related News Articles

Headline
New results from an ongoing clinical trial provide strong evidence that emergency departments can safely start buprenorphine treatment for opioid use disorder…
Headline
Medicare patients who have access to telehealth services and medications for opioid use disorder have lower risk of fatal drug overdose, according to a study…
Headline
Nonprofit hospitals and health systems and other eligible entities can apply until April 14 for up to $2.5 million from the Agency for Healthcare Research and…
Headline
The Food and Drug Administration yesterday issued a report offering recommendations to address the opioid crisis and the role of analgesic oversight in…
Headline
Commenting today on a proposed rule to improve the exchange of patient records used in the treatment of substance use disorder, AHA said it supports the…
Headline
States, territories, health facilities and tribal organizations can apply through March 27 for up to $525,000 million each for residential treatment programs…